{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:29:39Z","timestamp":1794482979705,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Guidelines about febrile neutropenia in paediatric patients are not homogeneous; the best empiric treatment of this condition should be driven by local epidemiology. The Weighted-Incidence Syndromic Combination Antibiogram (WISCA) addresses the need for disease-specific local susceptibility evidence that could guide empiric antibiotic prescriptions based on outcome estimates of treatment regimens obtained as a weighted average of pathogen susceptibilities. This study developed a WISCA model to inform empirical antibiotic regimen selection for febrile neutropenia (FN) episodes in onco-haematological paediatric patients treated at two Italian paediatric tertiary centres.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We included blood cultures from patients with a bloodstream infection and neutropenia admitted to the Paediatric Haematology-Oncology wards in Padua and Genoa Hospitals from 2016 to 2021. WISCAs were developed by estimating the coverage of 20 antibiotics as monotherapy and of 21 combined regimens with a Bayesian probability distribution.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We collected 350 blood cultures, including 196\u00a0g-negative and 154\u00a0g-positive bacteria. Considering the most used antibiotic combinations, such as piperacillin\u2013tazobactam plus amikacin, the median coverage for the pool of bacteria collected in the study was 78%. When adding a glycopeptide, the median coverage increased to 89%, while the replacement of piperacillin\u2013tazobactam with meropenem did not provide benefits. The developed WISCAs showed that no monotherapy offered an adequate coverage rate for the identified pathogens.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The application of WISCA offers the possibility of maximizing the clinical utility of microbiological surveillance data derived from large hospitals to inform the choice of the best empiric treatment while contributing to spare broad-spectrum antibiotics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12941-024-00673-8","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T15:03:09Z","timestamp":1708009389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Application of the Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide the empiric antibiotic treatment of febrile neutropenia in oncological paediatric patients: experience from two paediatric hospitals in Northern Italy"],"prefix":"10.1186","volume":"23","author":[{"given":"Cecilia","family":"Liberati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Don\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Maestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Petris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Gallocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pierobon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Calore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annachiara","family":"Zin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Brigadoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Mesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Saffioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Ugolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Castagnola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"issue":"9","key":"673_CR1","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1200\/jco.22.02224","volume":"41","author":"T Lehrnbecher","year":"2023","unstructured":"Lehrnbecher T, Robinson PD, Ammann RA, et al. Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update. J Clin Oncol. 2023;41(9):1774\u201385. https:\/\/doi.org\/10.1200\/jco.22.02224.","journal-title":"J Clin Oncol"},{"issue":"20","key":"673_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1470-2045(20)30725-7","volume":"2045","author":"T Lehrnbecher","year":"2021","unstructured":"Lehrnbecher T, Averbuch D, Castagnola E, et al. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol. 2021;2045(20):1\u201311. https:\/\/doi.org\/10.1016\/s1470-2045(20)30725-7.","journal-title":"Lancet Oncol"},{"issue":"3","key":"673_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ANTIBIOTICS10030266","volume":"10","author":"E Castagnola","year":"2021","unstructured":"Castagnola E, Bagnasco F, Mesini A, et al. Antibiotic resistant bloodstream infections in pediatric patients receiving chemotherapy or hematopoietic stem cell transplant: factors associated with development of resistance, intensive care admission and mortality. Antibiot (Basel, Switzerland). 2021;10(3):1\u201314. https:\/\/doi.org\/10.3390\/ANTIBIOTICS10030266.","journal-title":"Antibiot (Basel, Switzerland)"},{"issue":"5","key":"673_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1473-3099(10)70089-x","volume":"1\u20132","author":"JE Bennett","year":"2014","unstructured":"Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. Mand Douglas, Bennett\u2019s Princ Pract Infect Dis. 2014;1\u20132(5):1\u20133697. https:\/\/doi.org\/10.1016\/s1473-3099(10)70089-x.","journal-title":"Mand Douglas, Bennett\u2019s Princ Pract Infect Dis"},{"issue":"3","key":"673_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1086\/650446","volume":"31","author":"J Christoff","year":"2010","unstructured":"Christoff J, Tolentino J, Mawdsley E, Matushek S, Pitrak D, Weber SG. Optimizing empirical antimicrobial therapy for infection due to gram-negative pathogens in the intensive care unit: utility of a combination antibiogram. Infect Control Hosp Epidemiol. 2010;31(3):256\u201361. https:\/\/doi.org\/10.1086\/650446.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2 February","key":"673_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0246654","volume":"16","author":"M Stergiotis","year":"2021","unstructured":"Stergiotis M, Ammann RA, Droz S, Koenig C, Abayie Agyeman PK. Pediatric fever in neutropenia with bacteremia\u2014Pathogen distribution and in vitro antibiotic susceptibility patterns over time in a retrospective single-center cohort study. PLoS ONE. 2021;16(2 February):1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0246654.","journal-title":"PLoS ONE"},{"issue":"3","key":"673_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/1060028015625658","volume":"50","author":"B Liang","year":"2016","unstructured":"Liang B, Wheeler JS, Blanchette LM. Impact of combination antibiogram and related education on inpatient fluoroquinolone prescribing patterns for patients with health care-associated pneumonia. Ann Pharmacother. 2016;50(3):172\u20139. https:\/\/doi.org\/10.1177\/1060028015625658.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"673_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1086\/664768","volume":"33","author":"C Hebert","year":"2012","unstructured":"Hebert C, Ridgway J, Vekhter B, Brown EC, Weber SG, Robicsek A. Demonstration of the weighted-incidence syndromic combination antibiogram: an empiric prescribing decision aid. Infect Control Hosp Epidemiol. 2012;33(4):381\u20138. https:\/\/doi.org\/10.1086\/664768.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"673_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/S13756-021-00939-2","author":"E Barbieri","year":"2021","unstructured":"Barbieri E, Bottigliengo D, Tellini M, et al. Development of a Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide the choice of the empiric antibiotic treatment for urinary tract infection in paediatric patients: a Bayesian approach. Antimicrob Resist Infect Control. 2021. https:\/\/doi.org\/10.1186\/S13756-021-00939-2.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"18","key":"673_CR10","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","volume":"35","author":"T Lehrnbecher","year":"2019","unstructured":"Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2019;35(18):2082.","journal-title":"J Clin Oncol"},{"key":"673_CR11","unstructured":"eucast: New S, I and R definitions. https:\/\/www.eucast.org\/newsiandr. Accessed 6 Dec 2022."},{"issue":"3","key":"673_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/jac\/dkv397","volume":"71","author":"JA Bielicki","year":"2016","unstructured":"Bielicki JA, Sharland M, Johnson AP, et al. Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data. J Antimicrob Chemother. 2016;71(3):794\u2013802. https:\/\/doi.org\/10.1093\/jac\/dkv397.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"673_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214710","volume":"14","author":"Z Tandogdu","year":"2019","unstructured":"Tandogdu Z, Kakariadis ETA, Naber K, Wagenlehner F, Johansen TEB. Appropriate empiric antibiotic choices in health care associated urinary tract infections in urology departments in Europe from 2006 to 2015: a Bayesian analytical approach applied in a surveillance study. PLoS ONE. 2019;14(4): e0214710. https:\/\/doi.org\/10.1371\/journal.pone.0214710.","journal-title":"PLoS ONE"},{"key":"673_CR14","unstructured":"R: A Language and Environment for Statistical Computing. https:\/\/www.gnu.org\/copyleft\/gpl.html. Accessed 13 Jan 2022."},{"issue":"3","key":"673_CR15","doi-asserted-by":"publisher","first-page":"R112","DOI":"10.1186\/cc13901","volume":"18","author":"V Randhawa","year":"2014","unstructured":"Randhawa V, Sarwar S, Walker S, Elligsen M, Palmay L, Daneman N. Weighted-incidence syndromic combination antibiograms to guide empiric treatment of critical care infections: a retrospective cohort study. Crit Care. 2014;18(3):R112. https:\/\/doi.org\/10.1186\/cc13901.","journal-title":"Crit Care"},{"key":"673_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-021-00939-2","author":"E Barbieri","year":"2020","unstructured":"Barbieri E, Bottigliengo D, Tellini M, et al. Development of a Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide the choice of the empiric antibiotic treatment for urinary tract infection in paediatric patients: a Bayesian approach. Antimicrob Resist Infect Control. 2020. https:\/\/doi.org\/10.1186\/s13756-021-00939-2.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"673_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/14787210.2021.1967145","volume":"20","author":"A Cook","year":"2022","unstructured":"Cook A, Sharland M, Yau Y, PediBSI Group, Bielicki J. Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA). Expert Rev Anti Infect Ther. 2022;20(3):445\u201356. https:\/\/doi.org\/10.1080\/14787210.2021.1967145.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"8","key":"673_CR18","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/PBC.24485","volume":"60","author":"M Fletcher","year":"2013","unstructured":"Fletcher M, Hodgkiss H, Zhang S, et al. Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer. Pediatr Blood Cancer. 2013;60(8):1299\u2013306. https:\/\/doi.org\/10.1002\/PBC.24485.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"673_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/PBC.25435","volume":"62","author":"JL Salstrom","year":"2015","unstructured":"Salstrom JL, Coughlin RL, Pool K, et al. Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs. Pediatr Blood Cancer. 2015;62(5):807\u201315. https:\/\/doi.org\/10.1002\/PBC.25435.","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"673_CR20","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1086\/522533","volume":"45","author":"E Castagnola","year":"2007","unstructured":"Castagnola E, Fontana V, Caviglia I, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis. 2007;45(10):1296\u2013304. https:\/\/doi.org\/10.1086\/522533.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"673_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/INF.0B013E31828AEBC8","volume":"32","author":"GM Haeusler","year":"2013","unstructured":"Haeusler GM, Mechinaud F, Daley AJ, et al. Antibiotic-resistant Gram-negative bacteremia in pediatric oncology patients\u2013risk factors and outcomes. Pediatr Infect Dis J. 2013;32(7):723\u20136. https:\/\/doi.org\/10.1097\/INF.0B013E31828AEBC8.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"673_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/J.IJANTIMICAG.2006.08.007","volume":"28","author":"A Simon","year":"2006","unstructured":"Simon A, Gr\u00f6ger N, Wilkesmann A, et al. Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia. Int J Antimicrob Agents. 2006;28(5):417\u201322. https:\/\/doi.org\/10.1016\/J.IJANTIMICAG.2006.08.007.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"673_CR23","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/CID\/CIY1031","volume":"69","author":"AM Cressman","year":"2019","unstructured":"Cressman AM, Macfadden DR, Verma AA, Razak F, Daneman N. Empiric antibiotic treatment thresholds for serious bacterial infections: a scenario-based survey study. Clin Infect Dis. 2019;69(6):930\u20137. https:\/\/doi.org\/10.1093\/CID\/CIY1031.","journal-title":"Clin Infect Dis"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00673-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-024-00673-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00673-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T15:04:13Z","timestamp":1708009453000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-024-00673-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1186\/s12941-024-00673-8","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"assertion":[{"value":"3 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethic Committee for the clinical sperimentation of Padua, code AOP0790.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}